Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Phase II Neoadjuvant Biomarker Study of AC Followed by Ixabepilone vs Paclitaxel
2006-003047-24Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ixabepilone in breast cancer (2 arms), sponsored by Bristol Myers Squibb. Primary endpoints: Pathologic complete response rate and Biomarker-based predictive models. Started Apr 2007; status: completed.
02
Drugs
ixabepilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2006-003047-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003047-24.